Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.

Name: Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.
Author: Kimura, Yukishige

Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats. — المؤلف: Kimura, Yukishige — Journal of diabetes investigation 20200113

المؤلف: Kimura, Yukishige
النشر: Journal of diabetes investigation 20200113
الوصف: 933-946 p.
الموضوعات: Acute Kidney Injury؛ Animals؛ Canagliflozin؛ Cardio-Renal Syndrome؛ Diabetes Mellitus, Type 2؛ Lipid Peroxidation؛ Male؛ Myocardial Infarction